149 related articles for article (PubMed ID: 1541824)
1. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
Murray HW; Squires KE; Miralles CD; Stoeckle MY; Granger AM; Granelli-Piperno A; Bogdan C
J Immunol; 1992 Mar; 148(6):1858-63. PubMed ID: 1541824
[TBL] [Abstract][Full Text] [Related]
2. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
3. Role and effect of IL-2 in experimental visceral leishmaniasis.
Murray HW; Miralles GD; Stoeckle MY; McDermott DF
J Immunol; 1993 Jul; 151(2):929-38. PubMed ID: 8335921
[TBL] [Abstract][Full Text] [Related]
4. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
[TBL] [Abstract][Full Text] [Related]
5. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
6. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
8. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.
Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F
J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296
[TBL] [Abstract][Full Text] [Related]
9. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
Tumang MC; Keogh C; Moldawer LL; Helfgott DC; Teitelbaum R; Hariprashad J; Murray HW
J Immunol; 1994 Jul; 153(2):768-75. PubMed ID: 8021511
[TBL] [Abstract][Full Text] [Related]
10. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Himeno K
J Med Invest; 2001 Feb; 48(1-2):73-80. PubMed ID: 11286020
[TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
12. Effector role of blood monocytes in experimental visceral leishmaniasis.
Cervia JS; Rosen H; Murray HW
Infect Immun; 1993 Apr; 61(4):1330-3. PubMed ID: 8454335
[TBL] [Abstract][Full Text] [Related]
13. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
14. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
15. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
[TBL] [Abstract][Full Text] [Related]
16. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
17. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
Guilloteau L; Buzoni-Gatel D; Bernard F; Lantier I; Lantier F
Microb Pathog; 1993 Jan; 14(1):45-55. PubMed ID: 8321117
[TBL] [Abstract][Full Text] [Related]
18. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
20. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]